"Head and neck squamous cell carcinoma (HNSCC) ranks sixth worldwide for cancer-related mortality. Research in cancer biology has led to the discovery that many cancers, including HNSCC, appear to be supported by cells that have stem cell like properties. Further, CD44+ population was identified as cancer stem cells in Head and Neck Squamous cell carcinoma. These cancer stem cells have the ability to self-renew, differentiate and develop resistance against chemotherapeutic agents preventing complete elimination of tumor. It was shown these stem cells show abnormal Wnt/B-catenin signaling.